Literature DB >> 7611127

Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable cardioverter defibrillator.

S Behrens1, M Galecka, T Brüggemann, C Ehlers, S N Willich, W Ziss, R Dissmann, D Andresen.   

Abstract

To determine the circadian variation of sustained ventricular tachyarrhythmias, 78 consecutive patients with an implanted cardioverter defibrillator were analyzed with regard to the occurrence of spontaneous shock episodes during a mean follow-up period of 18 +/- 12 months. In 39 patients 207 shock episodes that terminated potentially life-threatening ventricular tachyarrhythmias could be related to an exact time of onset. A circadian variation (p < 0.001) of these events was demonstrated, with a primary morning peak between 7 hours and 11 hours and a secondary, much smaller peak between 16 hours and 20 hours. This finding indicates the relevance of endogeneous or exogeneous triggers in the cause of malignant arrhythmias that potentially lead to sudden cardiac death. Subgroup analyses revealed an association of the circadian pattern to the New York Heart Association functional classification, indicating perhaps a different role of triggers in different patient populations.

Entities:  

Mesh:

Year:  1995        PMID: 7611127     DOI: 10.1016/0002-8703(95)90239-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  Chronotherapeutics for cardiovascular disease.

Authors:  Y A Anwar; W B White
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

Review 2.  The role of clock genes and circadian rhythm in the development of cardiovascular diseases.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Cell Mol Life Sci       Date:  2015-05-14       Impact factor: 9.261

3.  Influence of the Circadian System on Disease Severity.

Authors:  Mikhail Litinski; Frank Ajl Scheer; Steven A Shea
Journal:  Sleep Med Clin       Date:  2009-06-01

4.  [Circadian variation of ventricular tachyarrhythmias in patients with an implantable cardioverter-defibrillator].

Authors:  C Wolpert; W Jung; S Spehl; T Korte; B Lüderitz
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-03

5.  Unexpected deviation in circadian variation of ventricular arrhythmias: the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

Authors:  Kristen K Patton; Anne S Hellkamp; Kerry L Lee; Daniel B Mark; George W Johnson; Jill Anderson; Gust H Bardy; Jeanne E Poole
Journal:  J Am Coll Cardiol       Date:  2014-04-16       Impact factor: 24.094

6.  Circadian variation in ventricular tachycardia and atrial fibrillation in a medical-cardiological ICU.

Authors:  Georg Delle Karth; Peter Reinelt; Anton Buberl; Alexander Geppert; Martin Huelsmann; Rudolf Berger; Gottfried Heinz
Journal:  Intensive Care Med       Date:  2003-04-16       Impact factor: 17.440

Review 7.  Circadian clock and the onset of cardiovascular events.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

8.  Methods of assessment and clinical relevance of QT dynamics.

Authors:  Beata Sredniawa; Agata Musialik-Lydka; Piotr Jarski; Anna Sliwinska; Zbigniew Kalarus
Journal:  Indian Pacing Electrophysiol J       Date:  2005-07-01

9.  Circadian pattern of short-term variability of the QT-interval in primary prevention ICD patients - EU-CERT-ICD methodological pilot study.

Authors:  David J Sprenkeler; Anton E Tuinenburg; Henk J Ritsema van Eck; Marek Malik; Markus Zabel; Marc A Vos
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

10.  Circadian Pattern of Acute Myocardial Infarction and Atrial Fibrillation in a Mediterranean Country: A study in Diabetic Patients.

Authors:  Stylianos Daios; Christos Savopoulos; Ilias Kanellos; Christos Argyrios Goudis; Ifigeneia Nakou; Stergiani Petalloti; Nicolas Hadjidimitriou; Dimitrios Pilalas; Antonios Ziakas; Georgia Kaiafa
Journal:  Medicina (Kaunas)       Date:  2021-01-06       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.